Global Peptide Therapeutics Market 2019-2023| Industry Analysis and Forecast| Technavio
LONDON--(BUSINESS WIRE)--Jan 3, 2019-- analysts forecast the global peptide therapeutics market to grow at a CAGR of approximately 9% during the forecast period, according to their latest market research report.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190102005680/en/
Technavio has published a new market research report on the global peptide therapeutics market from 2019-2023. (Graphic: Business Wire)
The collaborations for R&D is one of the major trends being witnessed in the . There is an increase in the approval of drugs in the peptide therapeutics market in recent years, owing to the growing strategic collaboration among market players for R&D in novel therapies. The companies have been entering strategic alliances to overcome technological and research challenges. The partnerships involve the transfer of technology, collaborative efforts in conducting studies in specific regions and easing the approval process at a regional level.
According to Technavio analysts, one of the key factors contributing to the growth of the global peptide therapeutics market is the growing cases of chronic diseases:
Global peptide therapeutics market: Growing cases of chronic diseases
The increasing instances of chronic diseases such as cancer, diabetes, obesity, and various cardiovascular diseases are one of the primary drivers of the global peptide therapeutics market. Peptides are known to possess high efficacy in the treatment of these diseases. Thus, with the growing prevalence of chronic conditions, the use of peptides has increased significantly in recent years.
According to a senior research analyst at Technavio, “The high prevalence of chronic conditions results in significant demand for curative drugs such as peptides, which drives market growth. Besides, the substantial need for the treatment of these diseases has led to various pharmaceutical companies developing therapies, including peptide-based drugs.”
Global peptide therapeutics market: Segmentation analysis
The global peptide therapeutics market research report provides market segmentation by RoA (parenteral, oral, and others) and by region (the Americas, EMEA, and APAC). It provides an in-depth analysis of the prominent factors influencing the market, including drivers, opportunities, trends, and industry-specific challenges.
The parenteral segment held the largest market share in 2018, accounting for more than 82% of the market. This segment is expected to dominate the global market throughout the forecast period.
The Americas led the market in 2018 with a market share of more than 45%. It was followed by EMEA and APAC respectively. The Americas is expected to dominate the market through 2022.
Technavio’s sample reports are free of charge and contain multiple sections of the report such as the market size and forecast, drivers, challenges, trends, and more.
Some of the key topics covered in the report include:
Market LandscapeMarket ecosystem Market characteristics Market segmentation analysis
Market SizingMarket definition Market size and forecast
Five Forces Analysis
Geographical SegmentationRegional comparison Key leading countries
Vendor LandscapeVendors covered Vendor classification Market positioning of vendors Competitive scenario
is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions.
With over 500 specialized analysts, Technavio’s report library consists of more than 10,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio’s comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.
If you are interested in more information, please contact our media team at .
View source version on businesswire.com:https://www.businesswire.com/news/home/20190102005680/en/
CONTACT: Technavio Research
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
INDUSTRY KEYWORD: HEALTH PHARMACEUTICAL
SOURCE: Technavio Research
Copyright Business Wire 2019.
PUB: 01/03/2019 01:02 AM/DISC: 01/03/2019 01:01 AM